ODTX
Odyssey Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.79
+9.05%Margins
Gross margin
100.0%
EBITDA margin
-4860.4%
EBIT margin
-5415.2%
Net margin
-4994.9%
FCF margin
-4391.8%
-35.3%
Return on equity
-30.7%
Return on assets
-36.1%
Return on invested capital
0.01x
Asset turnover
-$129.5M
Cash from operations
$6.46
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026